Meet BIOTYPE at ESGO 2024!

We are pleased to introduce our participation at the 25th European Congress on Gynaecological Oncology, taking place from 7th – 10th March in Barcelona, Spain.

Genetic analysis of solid tumors is crucial for effective cancer diagnosis, staging, and treatment. Our solutions enable precise molecular tumor analysis on standard real-time PCR systems. For a comprehensive approach, explore our MODAPLEX platform, which streamlines multi-marker and multi-gene analysis within 4 hours including data analysis and report compilation.

Join us at booth #05 and discover more about our new MODAPLEX generation with the demo instrument on our booth! Additionally, learn more about our MODAPLEX assay portfolio for molecular analysis of actionable biomarkers! Our Endometrium Cancer panel includes assays for testing POLE/POLD1, MSI and Copy Number High, following the ESGO recommended molecular-based TCGA classification for endometrial cancer.

Interested in learning more about MODAPLEX?

Meet with our delegates at Booth 05! They will be happy to answer all your questions and to discuss how BIOTYPE can help facilitate the optimal application for your diagnostic needs.